Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients

Seminars in Arthritis and Rheumatism
Athanasios N GeorgiadisAlexandros A Drosos

Abstract

To investigate subclinical atherosclerosis and the effect of treatment in patients with early rheumatoid arthritis (RA). Forty patients with early RA who met the revised American College of Rheumatology (ACR) criteria and disease duration of <1 year were included in the study. Smokers and patients with classical risk factors for atherosclerosis were excluded. The serum levels of total cholesterol (TC), triglycerides, high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol were determined in all patients before and after 1 year of therapy. Carotid artery intima-media thickness (IMT) and carotid plaque were measured before and after treatment. RA disease activity was measured using the 28 joint indices score (DAS-28) and clinical improvement was determined by the ACR response criteria. Forty-five age- and sex-matched nonsmoking volunteers were used as controls. All patients were treated with methotrexate and prednisone. RA patients had a baseline mild dyslipidemia characterized by a decrease in serum HDL-C levels and a high TC/HDL-C atherogenic ratio compared with controls. Both lipid parameters were significantly improved after treatment (P<0.01). Common carotid artery IMTs at baseline were higher i...Continue Reading

References

Jun 1, 1997·Annals of the Rheumatic Diseases·R MunroH A Capell
Apr 28, 2000·Annals of the Rheumatic Diseases·S Manzi, M C Wasko
Jul 13, 2002·Annals of the New York Academy of Sciences·G RodriguezF Nobili
Jul 19, 2002·Arthritis and Rheumatism·Yong-Beom ParkSoo-Kon Lee
Mar 12, 2003·Circulation·Daniel H SolomonGary C Curhan
Dec 14, 2004·Arthritis and Rheumatism·Inmaculada del RincónAgustín Escalante
Aug 9, 2005·Seminars in Arthritis and Rheumatism·Miguel A Gonzalez-GayJavier Martin
Feb 24, 2006·Annals of Internal Medicine·Mary J RomanJane E Salmon
Jun 28, 2006·Neurology·Wojciech AmbrosiusWojciech Kozubski
Jul 21, 2006·Annals of the New York Academy of Sciences·Bruno SerioloMaurizio Cutolo
Jul 29, 2006·Arthritis and Rheumatism·Samy SuissaMarie Hudson
Nov 7, 2006·Journal of the American College of Cardiology·Andreas A MeyerWolfgang Kienast
Mar 3, 2007·Arthritis and Rheumatism·John M DavisSherine E Gabriel

❮ Previous
Next ❯

Citations

Dec 16, 2011·Arthritis Research & Therapy·Lodewijk de GrootMarcel D Posthumus
Sep 11, 2010·Expert Review of Cardiovascular Therapy·Elena BartoloniRoberto Gerli
Nov 26, 2013·Rheumatic Diseases Clinics of North America·Deepali SenRichard D Brasington
Dec 27, 2011·European Journal of Pharmacology·Amany A AbdinAmira A E El-Saadany
Oct 5, 2010·Seminars in Arthritis and Rheumatism·Alper M van SijlMichael T Nurmohamed
Jun 15, 2010·Autoimmunity Reviews·Elena BartoloniRoberto Gerli
May 1, 2010·Atherosclerosis·Zeynep OzbalkanManfredi Rizzo
Feb 11, 2010·Clinical Biochemistry·Dina ShahinMaha Houssen
Dec 5, 2009·The American Journal of Medicine·Alice B Gottlieb, Frank Dann
Feb 27, 2015·Thrombosis and Haemostasis·Pasquale AmbrosinoMatteo Nicola Dario Di Minno
Jul 6, 2010·European Journal of Clinical Investigation·Lodewijk de GrootMarc Bijl
Apr 1, 2011·Arthritis Care & Research·Henry R Kramer, Jon T Giles
Dec 30, 2014·International Journal of Rheumatic Diseases·Vachana Murunikkara, Mahaboob K Rasool
May 20, 2015·Current Treatment Options in Neurology·Namrata Dhillon, Kimberly Liang
Apr 29, 2015·Atherosclerosis·Razi KhanPhilippe L L'Allier
Feb 24, 2009·Best Practice & Research. Clinical Rheumatology·Holly JohnNicola Goodson
Oct 16, 2013·Atherosclerosis·D F van Breukelen-van der StoepM Castro Cabezas
Mar 19, 2016·The British Journal of Dermatology·M K RutterC E M Griffiths
Feb 7, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·A Martinez-LopezS Arias-Santiago
Aug 2, 2012·Therapeutic Advances in Musculoskeletal Disease·Jonathan L Marks, Christopher J Edwards
Feb 13, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Pascal N TyrrellTimothy J Bradley
Nov 3, 2010·The Journal of Rheumatology·Amal M El-BarbaryRaghda G Ismail
Aug 16, 2008·Rheumatology International·Jacob N AblinYonit Wohl
Jul 23, 2011·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Bożena Targońska-StepniakMaria Majdan

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.